Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.72 USD | +3.55% | +3.73% | -2.65% |
Mar. 19 | Intra-Cellular Therapies CFO Hineline Retiring, Promotes Halstead to President | MT |
Mar. 19 | Intra-Cellular Therapies, Inc. Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.65% | 6.75B | |
+0.44% | 90.27B | |
+10.00% | 44.05B | |
-16.40% | 31.45B | |
+44.23% | 23.35B | |
-8.10% | 16.72B | |
-25.64% | 15.09B | |
-9.03% | 12.82B | |
-9.37% | 11.95B | |
+98.58% | 7.67B |
- Stock
- Equities
- Stock Intra-Cellular Therapies, Inc. - Nasdaq
- News Intra-Cellular Therapies, Inc.
- Jefferies Adjusts Price Target for Intra-Cellular Therapies to $85 From $70, Maintains Buy Rating